clorazepate dipotassium has been researched along with sb 243213 in 1 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (sb 243213) | Trials (sb 243213) | Recent Studies (post-2010) (sb 243213) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 21 | 0 | 1 |
| Protein | Taxonomy | clorazepate dipotassium (IC50) | sb 243213 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0324 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0007 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brocco, M; Dekeyne, A; Gobert, A; Millan, MJ | 1 |
1 other study(ies) available for clorazepate dipotassium and sb 243213
| Article | Year |
|---|---|
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Chemistry; Clorazepate Dipotassium; Conflict, Psychological; Dose-Response Relationship, Drug; Hippocampus; Indoles; Interpersonal Relations; Male; Melatonin; Mice; Microdialysis; Motor Activity; Norepinephrine; Pyridines; Rats; Receptor, Serotonin, 5-HT2C; Receptors, GABA-A; Serotonin; Serotonin Antagonists; Synaptic Transmission; Thiophenes; Vocalization, Animal | 2005 |